Dr Andrew Baxter

Dr Andrew Baxter has been a Consultant Gastroenterologist at Nottingham University Hospitals NHS Trust since 2021, delivering high-quality care within one of the UK’s largest tertiary university teaching centres. His clinical focus is on pancreatic disease and hepatobiliary medicine, a subspecialty portfolio built on a rigorous two-year fellowship in advanced endoscopy. As an independent practitioner of complex therapeutic endoscopy, he maintains a high-volume practice in ERCP and performs both diagnostic and therapeutic Endoscopic Ultrasound (EUS) alongside luminal stenting with consistently excellent technical success and safety outcomes. In the outpatient setting, Dr Baxter co-leads the multidisciplinary team clinics for Chronic Pancreatitis and cystic fibrosis-related liver and gastrointestinal disease, serving as a regional referral hub for these intricate conditions. He also provides 24/7 emergency gastroenterology services, adeptly managing acute upper gastrointestinal haemorrhage and performing urgent therapeutic endoscopy. Complementing his subspecialist work, Dr Baxter sustains a robust general gastroenterology workload, overseeing inpatient luminal disorders and a wide array of outpatient GI conditions. This blend of advanced procedural expertise, multidisciplinary leadership, and comprehensive general practice makes Dr Baxter a pivotal asset to the Trust’s digestive health service.

Dr Baxter’s clinical interests centre on pancreatic and hepatobiliary disease and advanced therapeutic endoscopy. His expertise covers the full spectrum of pancreatic and biliary disease, including pancreatitis, cysts, gallstones, and strictures. He also manages cystic fibrosis-related gastrointestinal and liver disease, functional GI disorders, and bile acid malabsorption. As an advanced endoscopist, he performs ERCP (cannulation, stone extraction, stenting), diagnostic and therapeutic EUS for peripancreatic collections, luminal stenting, and emergency interventions for acute GI bleeding and endoscopic complications. He is adept at managing clinical complexity, delivering expert care for patients with high-risk and multifaceted conditions across his subspecialty spectrum.

Dr Baxter maintains an active research interest in the evolution of endoscopic technology. Although his primary responsibilities lie in clinical care and departmental governance, he contributes to the Endoscopy Unit’s research portfolio by evaluating novel devices and techniques, ensuring that his practice stays at the forefront of emerging innovations.

Dr Baxter is a fully accredited trainer and educator, holding RCP accreditation (Merit, 2015) and JAG certification as an Endoscopy Trainer (2022). Since 2021 he has served as Clinical and Educational Supervisor for resident doctors and physician associates, overseeing their long‑term development and conducting summative assessments. In the advanced endoscopy suite he delivers twice‑weekly, high-calibre training for senior fellows, providing real‑time feedback on technical performance, clinical decision‑making and patient safety during ERCP and other complex therapeutic procedures. He also contributes to the national education programme as a faculty member for tertiary‑level endoscopy masterclasses where he presents live cases and leads detailed discussions for consultants and trainees. He serves as faculty for the Endoscopy Emergency Simulation programme at Nottingham, training nursing and medical staff in human‑factors and safety principles for acute gastrointestinal emergencies. This combination of formal accreditation, hands‑on procedural mentorship, and curriculum leadership underscores Dr Baxter’s commitment to developing the next generation of Gastroenterology and Endoscopy professionals.

Dr Baxter has an active scholarly record that spans peer‑reviewed articles, oral and poster presentations, and flash talks at national gastroenterology meetings. He is a co‑author of three peer‑reviewed papers, including a randomized trial on educational videos to improve bowel‑preparation adequacy (Endoscopy International Open), a multicentre trainee‑led audit examining time to endoscopy for acute upper gastrointestinal bleeding (United European Gastroenterology Journal), and a review of endoscopic ultrasound utility in hepatopancreatobiliary disease (Manipal Journal of Medical Sciences). He has presented on both training infrastructure and clinical standards, specifically delivering the talk 'Gastroenterology Trainee Research Networks: the Experience So Far' and a pan-Midlands audit of urgent endoscopy timing at the 2018 BSG Annual Meeting. At poster sessions, Dr Baxter has highlighted service‑development work such as the implementation of a pre‑endoscopy consent clinic to optimise ERCP appropriateness (BSG LIVE 2025), a pilot study of percutaneous transhepatic cholangioscopy for altered anatomy and hilar strictures (BSG LIVE 2025), and innovative multimodal liver assessments using EUS‑guided pressure gradients, biopsies and variceal screening (BASL Annual Meeting 2025). Additional posters have addressed the diagnostic impact of biopsies in pancreato‑biliary cancers (BSG LIVE 2024), validation of predictive models for inadequate bowel preparation (BSG LIVE 2023), monitoring strategies for chronic pancreatitis (BSG Annual Meeting 2022), and outcomes of urgent endoscopy delays during the COVID‑19 lockdown (BSG Annual Meeting 2021). Earlier work includes a presentation on EUS‑guided liver biopsy (BASL 2019) and several trainee‑led network audits of acute upper GI bleeding (BSG Annual Meetings 2018). A flash presentation at BSG LIVE 2025 showcased his single‑centre experience with multimodal liver assessment using EUS‑guided techniques. Dr Baxter’s publications and presentations are available on request.

7

Dr Baxter has held senior leadership roles within Nottingham University Hospitals NHS Trust, demonstrating a strong blend of strategic vision and operational expertise. As Deputy Head of Service – Endoscopy (January 2025 to present), he provides oversight for a high‑volume tertiary endoscopy unit, ensuring compliance with JAG accreditation, maintaining rigorous quality‑assurance standards and safeguarding patient safety across all procedures. From January 2022 to January 2025 he served as Governance Lead for Gastroenterology, directing the department’s clinical governance framework, chairing morbidity‑and‑mortality meetings, investigating serious incidents and complex complaints, and leading the implementation of NICE and BSG guidelines while authoring local protocols on constipation and medication management. During the urgent COVID‑19 response in 2020, Dr Baxter established a rapid luminal gastroenterology pathway. Key initiatives included designing triage protocols, upskilling nurse endoscopists, and implementing a new clinic infrastructure adapting the service infrastructure to meet the unprecedented challenges of the pandemic. This track record underscores his capacity to drive service improvement, uphold clinical standards and lead multidisciplinary teams through complex, high‑pressure environments.

2